Table of Contents
Global Recurrent Glioblastoma Multiforme Treatment Market Research Report 2021
1 Recurrent Glioblastoma Multiforme Treatment Market Overview
1.1 Product Overview and Scope of Recurrent Glioblastoma Multiforme Treatment
1.2 Recurrent Glioblastoma Multiforme Treatment Segment by Type (Product Category)
1.2.1 Global Recurrent Glioblastoma Multiforme Treatment Production and CAGR (%) Comparison by Type (Product Category)( 2016 - 2027)
1.2.2 Global Recurrent Glioblastoma Multiforme Treatment Production Market Share by Type (Product Category) in 2020
1.2.3 AU - 105
1.2.4 Axitinib
1.2.5 AXL - 1717
1.2.6 AZD - 7451
1.2.7 Others
1.3 Global Recurrent Glioblastoma Multiforme Treatment Segment by Application
1.3.1 Recurrent Glioblastoma Multiforme Treatment Consumption (Sales) Comparison by Application ( 2016 - 2027)
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Global Recurrent Glioblastoma Multiforme Treatment Market by Region ( 2016 - 2027)
1.4.1 Global Recurrent Glioblastoma Multiforme Treatment Market Size (Value) and CAGR (%) Comparison by Region ( 2016 - 2027)
1.4.2 North America Status and Prospect ( 2016 - 2027)
1.4.3 Europe Status and Prospect ( 2016 - 2027)
1.4.4 Asia - Pacific Status and Prospect ( 2016 - 2027)
1.4.5 South America Status and Prospect ( 2016 - 2027)
1.4.6 Middle East & Africa Status and Prospect ( 2016 - 2027)
1.5 Global Market Size (Value) of Recurrent Glioblastoma Multiforme Treatment ( 2016 - 2027)
1.5.1 Global Recurrent Glioblastoma Multiforme Treatment Revenue Status and Outlook ( 2016 - 2027)
1.5.2 Global Recurrent Glioblastoma Multiforme Treatment Capacity, Production Status and Outlook ( 2016 - 2027)
2 Global Recurrent Glioblastoma Multiforme Treatment Market Competition by Manufacturers
2.1 Global Recurrent Glioblastoma Multiforme Treatment Capacity, Production and Share by Manufacturers ( 2016 - 2021)
2.1.1 Global Recurrent Glioblastoma Multiforme Treatment Capacity and Share by Manufacturers ( 2016 - 2021)
2.1.2 Global Recurrent Glioblastoma Multiforme Treatment Production and Share by Manufacturers ( 2016 - 2021)
2.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Share by Manufacturers ( 2016 - 2021)
2.3 Global Recurrent Glioblastoma Multiforme Treatment Average Price by Manufacturers ( 2016 - 2021)
2.4 Manufacturers Recurrent Glioblastoma Multiforme Treatment Manufacturing Base Distribution, Sales Area and Product Type
2.5 Recurrent Glioblastoma Multiforme Treatment Market Competitive Situation and Trends
2.5.1 Recurrent Glioblastoma Multiforme Treatment Market Concentration Rate
2.5.2 Recurrent Glioblastoma Multiforme Treatment Market Share of Top 3 and Top 5 Manufacturers
2.5.3 Mergers & Acquisitions, Expansion
3 Global Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue (Value) by Region ( 2016 - 2021)
3.1 Global Recurrent Glioblastoma Multiforme Treatment Capacity and Market Share by Region ( 2016 - 2021)
3.2 Global Recurrent Glioblastoma Multiforme Treatment Production and Market Share by Region ( 2016 - 2021)
3.3 Global Recurrent Glioblastoma Multiforme Treatment Revenue (Value) and Market Share by Region ( 2016 - 2021)
3.4 Global Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.5 North America Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.6 Europe Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.7 Asia - Pacific Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.8 South America Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
3.9 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
4 Global Recurrent Glioblastoma Multiforme Treatment Supply (Production), Consumption, Export, Import by Region ( 2016 - 2021)
4.1 Global Recurrent Glioblastoma Multiforme Treatment Consumption by Region ( 2016 - 2021)
4.2 North America Recurrent Glioblastoma Multiforme Treatment Production, Consumption, Export, Import ( 2016 - 2021)
4.3 Europe Recurrent Glioblastoma Multiforme Treatment Production, Consumption, Export, Import ( 2016 - 2021)
4.4 Asia - Pacific Recurrent Glioblastoma Multiforme Treatment Production, Consumption, Export, Import ( 2016 - 2021)
4.5 South America Recurrent Glioblastoma Multiforme Treatment Production, Consumption, Export, Import ( 2016 - 2021)
4.6 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Production, Consumption, Export, Import ( 2016 - 2021)
5 Global Recurrent Glioblastoma Multiforme Treatment Production, Revenue (Value), Price Trend by Type
5.1 Global Recurrent Glioblastoma Multiforme Treatment Production and Market Share by Type ( 2016 - 2021)
5.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Market Share by Type ( 2016 - 2021)
5.3 Global Recurrent Glioblastoma Multiforme Treatment Price by Type ( 2016 - 2021)
5.4 Global Recurrent Glioblastoma Multiforme Treatment Production Growth by Type ( 2016 - 2021)
6 Global Recurrent Glioblastoma Multiforme Treatment Market Analysis by Application
6.1 Global Recurrent Glioblastoma Multiforme Treatment Consumption and Market Share by Application ( 2016 - 2021)
6.2 Global Recurrent Glioblastoma Multiforme Treatment Consumption Growth Rate by Application ( 2016 - 2021)
6.3 Market Drivers and Opportunities
6.3.1 Potential Applications
6.3.2 Emerging Markets/Countries
7 Global Recurrent Glioblastoma Multiforme Treatment Manufacturers Profiles/Analysis
7.1 Boehringer Ingelheim GmbH
7.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.1.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
7.1.2.1 Product A
7.1.2.2 Product B
7.1.3 Boehringer Ingelheim GmbH Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.1.4 Main Business/Business Overview
7.2 Boston Biomedical, Inc.
7.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.2.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
7.2.2.1 Product A
7.2.2.2 Product B
7.2.3 Boston Biomedical, Inc. Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.2.4 Main Business/Business Overview
7.3 Bristol - Myers Squibb Company
7.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.3.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
7.3.2.1 Product A
7.3.2.2 Product B
7.3.3 Bristol - Myers Squibb Company Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.3.4 Main Business/Business Overview
7.4 Cantex Pharmaceuticals, Inc.
7.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.4.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
7.4.2.1 Product A
7.4.2.2 Product B
7.4.3 Cantex Pharmaceuticals, Inc. Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.4.4 Main Business/Business Overview
7.5 Cavion LLC
7.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.5.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
7.5.2.1 Product A
7.5.2.2 Product B
7.5.3 Cavion LLC Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.5.4 Main Business/Business Overview
7.6 Celldex Therapeutics, Inc.
7.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.6.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
7.6.2.1 Product A
7.6.2.2 Product B
7.6.3 Celldex Therapeutics, Inc. Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.6.4 Main Business/Business Overview
7.7 Coherus BioSciences, Inc.
7.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.7.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
7.7.2.1 Product A
7.7.2.2 Product B
7.7.3 Coherus BioSciences, Inc. Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.7.4 Main Business/Business Overview
7.8 Cortice Biosciences, Inc.
7.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.8.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
7.8.2.1 Product A
7.8.2.2 Product B
7.8.3 Cortice Biosciences, Inc. Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.8.4 Main Business/Business Overview
7.9 Eisai
7.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.9.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
7.9.2.1 Product A
7.9.2.2 Product B
7.9.3 Eisai Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.9.4 Main Business/Business Overview
7.10 Eli Lilly and Company
7.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors
7.10.2 Recurrent Glioblastoma Multiforme Treatment Product Category, Application and Specification
7.10.2.1 Product A
7.10.2.2 Product B
7.10.3 Eli Lilly and Company Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue, Price and Gross Margin ( 2016 - 2021)
7.10.4 Main Business/Business Overview
7.11 EnGeneIC Ltd
7.12 ERC Belgium SA
7.13 GenSpera, Inc.
7.14 Genzyme Corporation
7.15 GW Pharmaceuticals Plc
7.16 ImmunoCellular Therapeutics, Ltd.
8 Recurrent Glioblastoma Multiforme Treatment Manufacturing Cost Analysis
8.1 Recurrent Glioblastoma Multiforme Treatment Key Raw Materials Analysis
8.1.1 Key Raw Materials
8.1.2 Price Trend of Key Raw Materials
8.1.3 Key Suppliers of Raw Materials
8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
8.2.1 Raw Materials
8.2.2 Labor Cost
8.2.3 Manufacturing Expenses
8.3 Manufacturing Process Analysis of Recurrent Glioblastoma Multiforme Treatment
9 Industrial Chain, Sourcing Strategy and Downstream Buyers
9.1 Recurrent Glioblastoma Multiforme Treatment Industrial Chain Analysis
9.2 Upstream Raw Materials Sourcing
9.3 Raw Materials Sources of Recurrent Glioblastoma Multiforme Treatment Major Manufacturers in 2020
9.4 Downstream Buyers
10 Marketing Strategy Analysis, Distributors/Traders
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
11 Market Effect Factors Analysis
11.1 Technology Progress/Risk
11.1.1 Substitutes Threat
11.1.2 Technology Progress in Related Industry
11.2 Consumer Needs/Customer Preference Change
11.3 Economic/Political Environmental Change
12 Global Recurrent Glioblastoma Multiforme Treatment Market Forecast ( 2021 - 2027)
12.1 Global Recurrent Glioblastoma Multiforme Treatment Capacity, Production, Revenue Forecast ( 2021 - 2027)
12.1.1 Global Recurrent Glioblastoma Multiforme Treatment Capacity, Production and Growth Rate Forecast ( 2021 - 2027)
12.1.2 Global Recurrent Glioblastoma Multiforme Treatment Revenue and Growth Rate Forecast ( 2021 - 2027)
12.1.3 Global Recurrent Glioblastoma Multiforme Treatment Price and Trend Forecast ( 2021 - 2027)
12.2 Global Recurrent Glioblastoma Multiforme Treatment Production, Consumption , Import and Export Forecast by Region ( 2021 - 2027)
12.2.1 North America Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.2 Europe Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.3 Asia - Pacific Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.4 South America Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.2.5 Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Production, Revenue, Consumption, Export and Import Forecast ( 2021 - 2027)
12.3 Global Recurrent Glioblastoma Multiforme Treatment Production, Revenue and Price Forecast by Type ( 2021 - 2027)
12.4 Global Recurrent Glioblastoma Multiforme Treatment Consumption Forecast by Application ( 2021 - 2027)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
List of Tables and Figures
Figure Picture of Recurrent Glioblastoma Multiforme Treatment
Figure Global Recurrent Glioblastoma Multiforme Treatment Production (K Pcs) and CAGR (%) Comparison by Types (Product Category) ( 2016 - 2027)
Figure Global Recurrent Glioblastoma Multiforme Treatment Production Market Share by Types (Product Category) in 2020
Figure Product Picture of AU - 105
Table Major Manufacturers of AU - 105
Figure Product Picture of Axitinib
Table Major Manufacturers of Axitinib
Figure Product Picture of AXL - 1717
Table Major Manufacturers of AXL - 1717
Figure Product Picture of AZD - 7451
Table Major Manufacturers of AZD - 7451
Figure Product Picture of Others
Table Major Manufacturers of Others
Figure Global Recurrent Glioblastoma Multiforme Treatment Consumption (K Pcs) by Applications ( 2016 - 2027)
Figure Global Recurrent Glioblastoma Multiforme Treatment Consumption Market Share by Applications in 2020
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Recurrent Glioblastoma Multiforme Treatment Market Size (Million USD), Comparison (K Pcs) and CAGR (%) by Regions ( 2016 - 2027)
Figure North America Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Europe Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Asia - Pacific Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure South America Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Middle East & Africa Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) and Growth Rate ( 2016 - 2027)
Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) Status and Outlook ( 2016 - 2027)
Figure Global Recurrent Glioblastoma Multiforme Treatment Capacity, Production (K Pcs) Status and Outlook ( 2016 - 2027)
Figure Global Recurrent Glioblastoma Multiforme Treatment Major Players Product Capacity (K Pcs) ( 2016 - 2021)
Table Global Recurrent Glioblastoma Multiforme Treatment Capacity (K Pcs) of Key Manufacturers ( 2016 - 2021)
Table Global Recurrent Glioblastoma Multiforme Treatment Capacity Market Share of Key Manufacturers ( 2016 - 2021)
Figure Global Recurrent Glioblastoma Multiforme Treatment Capacity (K Pcs) of Key Manufacturers in 2020
Figure Global Recurrent Glioblastoma Multiforme Treatment Capacity (K Pcs) of Key Manufacturers in 2021
Figure Global Recurrent Glioblastoma Multiforme Treatment Major Players Product Production (K Pcs) ( 2016 - 2021)
Table Global Recurrent Glioblastoma Multiforme Treatment Production (K Pcs) of Key Manufacturers ( 2016 - 2021)
Table Global Recurrent Glioblastoma Multiforme Treatment Production Share by Manufacturers ( 2016 - 2021)
Figure 2020 Recurrent Glioblastoma Multiforme Treatment Production Share by Manufacturers
Figure 2020 Recurrent Glioblastoma Multiforme Treatment Production Share by Manufacturers
Figure Global Recurrent Glioblastoma Multiforme Treatment Major Players Product Revenue (Million USD) ( 2016 - 2021)
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) by Manufacturers ( 2016 - 2021)
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue Share by Manufacturers ( 2016 - 2021)
Table 2020 Global Recurrent Glioblastoma Multiforme Treatment Revenue Share by Manufacturers
Table 2021 Global Recurrent Glioblastoma Multiforme Treatment Revenue Share by Manufacturers
Table Global Market Recurrent Glioblastoma Multiforme Treatment Average Price (USD/Pcs) of Key Manufacturers ( 2016 - 2021)
Figure Global Market Recurrent Glioblastoma Multiforme Treatment Average Price (USD/Pcs) of Key Manufacturers in 2020
Table Manufacturers Recurrent Glioblastoma Multiforme Treatment Manufacturing Base Distribution and Sales Area
Table Manufacturers Recurrent Glioblastoma Multiforme Treatment Product Category
Figure Recurrent Glioblastoma Multiforme Treatment Market Share of Top 3 Manufacturers
Figure Recurrent Glioblastoma Multiforme Treatment Market Share of Top 5 Manufacturers
Table Global Recurrent Glioblastoma Multiforme Treatment Capacity (K Pcs) by Region ( 2016 - 2021)
Figure Global Recurrent Glioblastoma Multiforme Treatment Capacity Market Share by Region ( 2016 - 2021)
Figure Global Recurrent Glioblastoma Multiforme Treatment Capacity Market Share by Region ( 2016 - 2021)
Figure 2020 Global Recurrent Glioblastoma Multiforme Treatment Capacity Market Share by Region
Table Global Recurrent Glioblastoma Multiforme Treatment Production by Region ( 2016 - 2021)
Figure Global Recurrent Glioblastoma Multiforme Treatment Production (K Pcs) by Region ( 2016 - 2021)
Figure Global Recurrent Glioblastoma Multiforme Treatment Production Market Share by Region ( 2016 - 2021)
Figure 2020 Global Recurrent Glioblastoma Multiforme Treatment Production Market Share by Region
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue (Million USD) by Region ( 2016 - 2021)
Table Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Region ( 2016 - 2021)
Figure Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Region ( 2016 - 2021)
Table 2020 Global Recurrent Glioblastoma Multiforme Treatment Revenue Market Share by Region
